Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...
Individuals with interstitial lung disease (ILD) had more than a 13-fold higher incidence rate of lung cancer than those without ILD. The association persisted after adjustment for confounders, was ...
PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...
The novel radiotracer ¹⁸F-FAPI-RGD in PET/CT scans shows potential for diagnosing ILD in connective tissue disease patients by highlighting fibroblast activation and tissue remodeling. Patients with ...
New Delhi: A 65-year-old woman suffering from end-stage interstitial lung disease (ILD), caused by scleroderma, a rare autoimmune disorder, got a fresh lease of life after undergoing a complex ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback